Cancer Immunotherapy Guidelines Renal Cell Carcinoma Subcommittee

SITC Cancer Immunotherapy Guidelines (CIGs) are a collection of consensus statements developed by experts in the treatment of specific types of cancer. Each consensus statement provides key indicators to help practicing oncologists determine when and how to best use immunotherapy to treat their patients. These systematically developed recommendations promote enhanced clinical decisions concerning patient selection, toxicity management, clinical endpoints, and the sequencing or combination of therapies. The Renal Cell Carcinoma (RCC) Subcommittee was developed to generate consensus statements specifically for cancers of the kidneys.


Michael B. Atkins, MD
Georgetown Lombardi Comprehensive Cancer Center

Brian I. Rini, MD
Cleveland Clinic Cancer Center